TW200716082A - Combination and use of drugs - Google Patents

Combination and use of drugs

Info

Publication number
TW200716082A
TW200716082A TW095116932A TW95116932A TW200716082A TW 200716082 A TW200716082 A TW 200716082A TW 095116932 A TW095116932 A TW 095116932A TW 95116932 A TW95116932 A TW 95116932A TW 200716082 A TW200716082 A TW 200716082A
Authority
TW
Taiwan
Prior art keywords
drugs
combination
rimonabant
sibutramine
obesity
Prior art date
Application number
TW095116932A
Other languages
English (en)
Inventor
Peer B Jacobson
Michael E Brune
Eugene N Bush
Terry J Opgenorth
Christine A Collins
GELDERN Thomas VON
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of TW200716082A publication Critical patent/TW200716082A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW095116932A 2005-05-13 2006-05-12 Combination and use of drugs TW200716082A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68109605P 2005-05-13 2005-05-13

Publications (1)

Publication Number Publication Date
TW200716082A true TW200716082A (en) 2007-05-01

Family

ID=37431870

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095116932A TW200716082A (en) 2005-05-13 2006-05-12 Combination and use of drugs

Country Status (3)

Country Link
US (1) US20060276549A1 (zh)
TW (1) TW200716082A (zh)
WO (1) WO2006124506A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7674776B2 (en) 1999-06-14 2010-03-09 Vivus, Inc. Combination therapy for effecting weight loss and treating obesity
US20080103179A1 (en) 2006-10-27 2008-05-01 Tam Peter Y Combination Therapy
US20090304789A1 (en) 2008-06-09 2009-12-10 Thomas Najarian Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders
US8580298B2 (en) 2008-06-09 2013-11-12 Vivus, Inc. Low dose topiramate/phentermine composition and methods of use thereof
EP2395987A1 (en) 2009-02-12 2011-12-21 Coöperatieve Mirzorg U.A., Arnhem Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
HRP20200324T1 (hr) * 2013-03-19 2020-06-12 Universitat Pompeu-Fabra Antagonisti kanabinoidnog receptora cb1 za upotrebu u liječenju bolesti povezanih s neuronalnim dendritičkim abnormalnostima
NL2022615B1 (en) 2019-02-21 2020-08-31 Patrick Alexander Unger Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020091114A1 (en) * 2000-10-04 2002-07-11 Odile Piot-Grosjean Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity

Also Published As

Publication number Publication date
US20060276549A1 (en) 2006-12-07
WO2006124506A2 (en) 2006-11-23
WO2006124506A3 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
MX2010005909A (es) Combinacion de inhibidores de fosfatasa de proteina tirosina y hormona de crecimiento humana para el tratamiento de atrofia muscular y trastornos relacionados.
IL182222A0 (en) Treatment of bipolar disorders and associated symptoms
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
PH12011502704A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MY145439A (en) Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
IL188204A0 (en) Combination therapy for the treatment of immunoinflammatory disorders
NO20072558L (no) Mitotiske kineseinhibitorer og fremgangsmater for anvendelse derav
MY147767A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
TW200744642A (en) Novel peptides for use in the treatment of obesity
SG150531A1 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
CY1114448T1 (el) Φαρμακευτικες συνθεσεις και χρηση αυτων στην αγωγη της γυναικειας σεξουαλικης δυσλειτουργιας
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
MX2009008363A (es) Combinacion de un antagonista de receptor muscarinico y un agonista de receptor adrenergico beta 2.
SG146451A1 (en) Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorders in the depressed patient
TW200716082A (en) Combination and use of drugs
UA104714C2 (ru) Выделенный полинуклеотид brachyspira hyodysenteriae, кодирующий полипептид, и его применение
WO2007128588A3 (de) Glutadon
MXPA05011699A (es) Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
MX2010012019A (es) Producto farmaceutico que comprende un antagonista receptor muscarinico y un agonista de adrenoceptor beta2.